PlainRecalls
FDA Drug Moderate Class II Terminated

Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA NDC 70010-227-05

Reported: August 14, 2024 Initiated: July 31, 2024 #D-0634-2024

Product Description

Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA NDC 70010-227-05

Reason for Recall

Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets

Details

Units Affected
11,808 500-count Bottles
Distribution
Nationwide in the USA
Location
Chantilly, VA

Frequently Asked Questions

What product was recalled?
Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA NDC 70010-227-05. Recalled by Granules Pharmaceuticals Inc.. Units affected: 11,808 500-count Bottles.
Why was this product recalled?
Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets
Which agency issued this recall?
This recall was issued by the FDA Drug on August 14, 2024. Severity: Moderate. Recall number: D-0634-2024.